| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $36.1M | — | +80.1% |
| SG&A Expense | $7.4M | — | +118.2% |
| Operating Income | -$43.4M | — | -1182.7% |
| Pre-tax Income | -$40.4M | — | -5.7% |
| Income Tax | $16K | — | — |
| Net Income | -$40.4M | — | -1503.2% |
| EPS (Basic) | -$0.57 | — | -533.3% |
| EPS (Diluted) | -$0.57 | — | -533.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $55.1M | -37.7% | +24.6% |
| Short-term Investments | $256.2M | +3.4% | +700.9% |
| Current Assets | $318.5M | -8.7% | +311.7% |
| Total Assets | $319.4M | -8.7% | +312.0% |
| Current Liabilities | $22.3M | +34.8% | +822.3% |
| Total Liabilities | $23.0M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$24.1M | — | -911.4% |
| Investing Cash Flow | -$8.5M | — | -165.9% |
| Financing Cash Flow | -$795K | — | -13.6% |
| +823.6% |
| Stockholders' Equity | $296.5M | -10.8% | +295.0% |